| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
EOFLOW Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩12,060.00 |
| 52 Week High | ₩28,150.00 |
| 52 Week Low | ₩3,335.00 |
| Beta | 0.75 |
| 11 Month Change | -11.71% |
| 3 Month Change | 198.15% |
| 1 Year Change | -57.08% |
| 33 Year Change | -57.83% |
| 5 Year Change | n/a |
| Change since IPO | 20.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| A294090 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -2.0% | -2.7% | -4.0% |
| 1Y | -57.1% | 20.1% | 2.2% |
Return vs Industry: A294090 underperformed the KR Medical Equipment industry which returned 20.1% over the past year.
Return vs Market: A294090 underperformed the KR Market which returned 2.2% over the past year.
Price Volatility
| A294090 volatility | |
|---|---|
| A294090 Average Weekly Movement | 24.9% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.1% |
| 10% least volatile stocks in KR Market | 2.2% |
Stable Share Price: A294090's share price has been volatile over the past 3 months.
Volatility Over Time: A294090's weekly volatility has increased from 19% to 25% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 135 | Jesse Kim | www.eoflow.com |
EOFLOW Co.,Ltd. develops and provides drug delivery solutions. The company offers EOPatch, a wearable insulin pump system.
EOFLOW Co.,Ltd. Fundamentals Summary
| A294090 fundamental statistics | |
|---|---|
| Market cap | ₩367.05b |
| Earnings (TTM) | -₩61.00b |
| Revenue (TTM) | ₩6.97b |
52.7x
P/S Ratio-6.0x
P/E RatioIs A294090 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A294090 income statement (TTM) | |
|---|---|
| Revenue | ₩6.97b |
| Cost of Revenue | ₩9.84b |
| Gross Profit | -₩2.87b |
| Other Expenses | ₩58.13b |
| Earnings | -₩61.00b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.00k |
| Gross Margin | -41.26% |
| Net Profit Margin | -875.58% |
| Debt/Equity Ratio | 50.1% |
How did A294090 perform over the long term?
See historical performance and comparison